CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancer.
Boutin J, Genevois C, Couillaud F, Lamrissi-Garcia I, Guyonnet-Duperat V, Bibeyran A, Lalanne M, Amintas S, Moranvillier I, Richard E, Blouin JM, Dabernat S, Moreau-Gaudry F, Bedel A.
Boutin J, et al. Among authors: richard e.
Mol Ther Oncol. 2024 Feb 8;32(1):200772. doi: 10.1016/j.omton.2024.200772. eCollection 2024 Mar 21.
Mol Ther Oncol. 2024.
PMID: 38596305
Free PMC article.